AD-2321

· Addpharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD-2321, covering 2025-12-31 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322 [Phase 1]